Cleveland BioLabs

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Cleveland BioLabs ( CBLI) is a biotechnology company. CBLI is focused on developing biodefense, tissue protection and cancer treatment drugs based on the concept of modulation of cell death for therapeutic benefit. This stock is trading up 6.6 % at $2.28 in recent trading.

Today's Range: $2.14-$2.35

52-Week Range: $1.15-$4.06

Volume: 99,000

Three-Month Average Volume: 171,386

From a technical perspective, CBLI is trending higher here with light volume. This move has started to push CBLI back above its 200-day moving average of $2.25, and it's moving the stock within range of a near-term breakout trade. That trade will trigger once CBLI clears some near-term overhead resistance at $2.43 with high volume.

Traders should now look for long-biased trades in CBLI as long as it's trending above today's low of $2.14, and then once it sustains a move or close above $2.43 with volume that's near or above 171,386 shares. If that breakout triggers soon, then CBLI will have a great chance of re-testing or possibly taking out its next major overhead resistance levels at $3 to $3.50.

If you liked this article you might like

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

Transition Therapeutics (TTHI) Stock Climbs on Positive Alzheimer Treatment Data

5 Stocks Under $10 Set to Soar

2 Biotech Stocks Under $10 Triggering Breakouts

5 Stocks Under $10 to Trade for Breakouts